Isolated Liver Perfusion with Mitomycin C for Rat Liver Tumours
Author Information
Author(s): A. Marinelli, F.R. Dijkstra, J.H. van Dierendonck, P.J.K. Kuppen, C.J. Cornelisse, C.J.H. van de Velde
Primary Institution: University Hospital, Leiden, The Netherlands
Hypothesis
Does isolated liver perfusion with mitomycin C provide a more effective treatment for liver tumours compared to hepatic artery infusion?
Conclusion
Isolated liver perfusion with mitomycin C allows for higher doses that can lead to complete tumour remission in rats.
Supporting Evidence
- Five out of seven rats treated with isolated liver perfusion showed complete tumour remission.
- Isolated liver perfusion allowed for a higher dose of mitomycin C compared to hepatic artery infusion.
- Significant increases in the proportion of cells in mid and late S phase were observed after isolated liver perfusion.
Takeaway
The study shows that giving a special treatment directly to the liver can help get rid of liver cancer in rats better than giving it through the main artery.
Methodology
The study used a rat model with two tumours each, comparing isolated liver perfusion and hepatic artery infusion of mitomycin C, and analyzed tumour growth and cell cycle changes.
Limitations
The study was conducted on rats, and results may not directly translate to humans.
Participant Demographics
Male WAG/Ola rats weighing 250-300 g were used.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website